BlackRock Institutional Trust’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$748M	Buy	2,037,231 +19,389	+1%	+$7.37M	0.11%	187
2016 Q3	$811M	Buy	2,017,842 +7,547	+0.4%	+$3.03M	0.13%	162
2016 Q2	$702M	Buy	2,010,295 +49,006	+2%	+$18.9M	0.11%	177
2016 Q1	$707M	Buy	1,961,289 +13,215	+0.7%	+$5.45M	0.12%	170
2015 Q4	$1.06B	Buy	1,948,074 +9,653	+0.5%	+$5.23M	0.17%	114
2015 Q3	$902M	Buy	1,938,421 +5,335	+0.3%	+$2.87M	0.16%	124
2015 Q2	$986M	Sell	1,933,086 -82,743	-4%	-$40.4M	0.16%	127
2015 Q1	$910M	Buy	2,015,829 +28,849	+1%	+$12.2M	0.14%	142
2014 Q4	$815M	Sell	1,986,980 -17,113	-0.9%	-$6.73M	0.13%	164
2014 Q3	$723M	Sell	2,004,093 -92,116	-4%	-$30.9M	0.12%	166
2014 Q2	$592M	Buy	2,096,209 +35,120	+2%	+$10.4M	0.1%	208
2014 Q1	$619M	Sell	2,061,089 -17,068	-0.8%	-$5.26M	0.11%	190
2013 Q4	$572M	Buy	2,078,157 +29,453	+1%	+$8.47M	0.1%	201
2013 Q3	$641M	Buy	2,048,704 +6,718	+0.3%	+$1.77M	0.12%	162
2013 Q2	$459M	Buy	+2,041,986	New	+$476M	0.09%	218